EQL EQL Pharma AB (publ)

STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic · eqlpharma.com

23.05SEK-1.50%Mkt Cap: 66.09M $P/E: —Today

EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers prescription drugs, including h…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$64.70BUSDP/E 25.1

TAK

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

$57.06BUSD

TEVA

Teva Pharmaceutical Industries Limited Ordinary Shares

$46.10BUSDP/E 65.9

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$38.70BUSDP/E 18.3

ZTS

Zoetis Inc. Class A Common Stock

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

VTRS

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB

$14.24BUSDP/E 109.4

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated Common Stock

$11.06BUSD

RDY

Dr. Reddy's Laboratories Ltd Common Stock

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc. Class A Common Stock

$6.77BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

HIK

Hikma Pharmaceuticals PLC

$4.19BUSDP/E 11.9

Key Statistics

Company

Market Cap66.09M USD

Enterprise Value104.22M USD

Revenue (TTM)41.36M USD

Gross Profit15.58M USD

Net Income (TTM)1.20M USD

Revenue/Share14.58 SEK

Last Price23.05 SEK

Fiscal Year EndMar 2026

MR QuarterJun 2026

Employees65

CountrySE

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINSE0005497732

Valuation

P/E (Trailing)—

P/E (Forward)7.48

PEG—

EV/EBITDA31.75

EV/Revenue2.52

P/S1.60

P/B2.76

EPS (TTM)-0.48

EPS (Forward)3.13

52W Range

17.3811% of range70.60

52W High70.60 SEK

52W Low17.38 SEK

Profitability

Gross Margin37.64%

Oper. Margin-12.74%

EBITDA Margin7.94%

Profit Margin2.90%

ROE4.69%

ROA1.47%

Growth

Revenue Growth-0.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF2.71M USD

CapEx (TTM)6.43M USD

FCF Margin-6.88%

FCF Yield-4.31%

Net Debt38.13M USD

Net Debt/EBITDA11.62

Balance Sheet

Debt/Equity1.72

Current Ratio1.83

Quick Ratio0.83

Book Value/Sh8.48 SEK

Cash/Share2.07 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 SEK

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)47.50 SEK

Upside (mean)+106.1%

Target Range47.50 SEK – 47.50 SEK

# Analysts1

Ownership

Shares Out.29.53M

Float12.80M

Insiders57.70%

Institutions18.23%

Technical

SMA 5024.22 (-4.8%)

SMA 20039.30 (-41.3%)

Beta0.26

S&P 52W Chg14.58%

Avg Vol (30d)17.96K

Avg Vol (10d)14.54K

Technical Indicators

RSI (14)44.1

MACD-0.5884

MACD Signal-0.3751

MACD Hist.-0.2134

BB Upper27.84 SEK

BB Middle24.58 SEK

BB Lower21.32 SEK

BB Width26.53%

ATR (14)1.476 SEK

Vol Ratio (20d)1.63x